Archer Materials and GlobalFoundries work on industrial manufacturing of 12CQ chip technology

Archer Materials will access GlobalFoundries manufacturing facilities and processes to identify high-volume manufacturing pathways for 12CQ chip devices and components.

Archer Materials (ASX:AXE) has partnered with GlobalFoundries to work on the industrial manufacturing of its 12CQ quantum chip (12QC chip).

Described as one of the world’s leading semiconductor foundries, GlobalFoundries provides Archer with “the expertise, equipment and manufacturing processes” to further develop its 12CQ chip qubit technology.

Commenting on the deal with GlobalFoundries, Archer’s chief executive, Dr. Mohammad Choucair, said the company was now able to leverage GlobalFoundries’ capabilities to “accelerate the development” of this technology.

Archer’s goal is to ensure that its qubit materials are suitable for industrial-scale semiconductor nanofabrication, with the materials then to be incorporated into mobile-enabled devices.

To boost the production of its 12CQ chip devices and components, Archer recognized that it needed to partner with industrial-scale manufacturers in the global semiconductor supply chain.

Under the agreement announced today, Archer has access to GlobalFoundries’ facilities and manufacturing processes to help identify high-volume manufacturing pathways for the 12QC chip devices and components.

Dr. Choucair noted that current quantum computing qubit components depend on custom manufacturing. This compares to traditional computer circuits that are fabricated in established industrial semiconductor facilities.

He added that integrating qubit materials with industrial-scale foundries is a “significant challenge” in the development of quantum processors.

Archer is the only ASX-listed entity, and one of the few in the world, to develop qubit processor technology.

Nanofabrication of biochip devices

The agreement with GlobalFoundries follows Archer’s announcement last week that it had achieved a long-term goal of manufacturing biochip device components smaller than 10 nanometers (nm).

Archer began nanofabrication processes in April 2021 with the goal of developing features for sub-10nm biochips.

The company has now fabricated sub-10nm features “reproducibly and reliably” through the development of several advanced lithographic processes on a silicon wafer in a clean room environment.

“Achieving sub-10 nanometer manufacturing of electronic device components is an excellent achievement on our path to developing Archer’s biochip technology, and demonstrates the world-class capabilities of our pioneering team,” said the Dr Choucair.

Dr. Choucair says the company’s solid-state devices are “pushing the boundaries of modern technology.”

Comments are closed.